Background-Autonomic neuropathy provides a mechanism for the absence of symptoms in silent myocardial ischaemia, but characterisation of the type of neuropathy is lacking. Aim-To characterise and compare autonomic nerve function in patients with silent and symptomatic myocardial ischaemia. Methods and results-The Valsalva manoeuvre, heart rate variation (HRV) in response to deep breathing and standing, lower body negative pressure, isometric handgrip, and the cold pressor test were performed by patients with silent (n = 25) and symptomatic (n = 25) ambulatory ischaemia and by controls (n = 21). No difference in parasympathetic efferent function between patients with silent and symptomatic ischaemia was recorded, but both had significantly less HRV in response to standing than the controls (p < 0*005 for silent and p < 0*01 for symptomatic).
neuropathy provides a mechanism for the absence of symptoms in silent myocardial ischaemia, but characterisation of the type of neuropathy is lacking. Aim-To characterise and compare autonomic nerve function in patients with silent and symptomatic myocardial ischaemia.
Methods and results-The Valsalva manoeuvre, heart rate variation (HRV) in response to deep breathing and standing, lower body negative pressure, isometric handgrip, and the cold pressor test were performed by patients with silent (n = 25) and symptomatic (n = 25) ambulatory ischaemia and by controls (n = 21) . No difference in parasympathetic efferent function between patients with silent and symptomatic ischaemia was recorded, but both had significantly less HRV in response to standing than the controls (p < 0*005 for silent and p < 0*01 for symptomatic).
Patients with silent ischaemia showed an increased propensity for peripheral vasodilatation compared with symptomatic patients (p < 0.02) and controls (p < 0.04). Impaired sympathetic function was found in patients with pure silent ischaemia (n = 4) compared with the remaining patients with silent ischaemia whose pain pathways were presumed to be intact.
Concuions--Patients with silent ischaemia
and pain pathways presumed to be intact have an enhanced peripheral vasodilator response, and if this applied to the coronary vasculature it could provide a mechanism for limiting ischaemia to below the pain threshold. Patients with pure silent ischaemia have evidence of sympathetic autonomic dysfunction.
(Br Heart Y 1994;71: [22] [23] [24] [25] [26] [27] [28] [29] Cardiac autonomic afferent nerves were first found almost a century ago. ' 2 Parasympathetic and sympathetic afferents are thought to convey sensory data from the heart to modulate homoeostasis and regulate cardiac function through cardiocardiac reflexes. '-5 In humans, sympathetic afferent nerves are also thought to convey the symptom of angina in patients with ischaemic heart disease, and evidence for this is provided by finding that surgical rhizotomy (cervical sympathectomy) abolished angina in patients with ischaemic heart disease. 6 Silent ischaemia can be purely silent, can occur after myocardial infarction, or can coexist with symptomatic ischaemia.7 Postulated mechanisms of silent ischaemia include an altered pain threshold,8 subthreshold ischaemia insufficient to cause pain, and dysfunction of cardiac autonomic afferent nerves. In patients with pure silent ischaemia, autonomic afferent dysfunction is likely. This is supported by the fact that patients with diabetes mellitus and autonomic neuropathy have a high incidence of pure silent myocardial ischaemia9 10 although the type of neuropathy in such patients was not described. Afferent dysfunction is less likely in patients with previous symptoms in whom pain pathways are likely to be intact.
The aim of the study was to characterise and compare autonomic nerve function in patients with silent and symptomatic myocardial ischaemia and in controls.
Patients and methods

SUBJECT SELECTION
After approval by the ethics committee controls and patients with significant angiographic coronary artery disease () 50% narrowing in one or more major coronary arteries) gave was rested for 15 minutes or longer to restore baseline heart rate and blood pressure. Heart rate variation on standing was measured by calculating the ratio of the RR interval at the 30th and 15th beat after standing. Heart rate variation during deep breathing was then measured: subjects inspired and expired deeply six times for one minute, the maximal inspiratory and minimal expiratory RR intervals were recorded for each breathing cycle, averaged for the six cycles, and an expiratory to inspiratory ratio calculated.
The subject then performed isometric handgrip to assess peripheral vasodilation, which probably reflects a combination of sympathetic ,62 and atropine sensitive cholinergic effects.12 13 Measurements of heart rate, mean arterial pressure (cuff), plethysmographic forearm blood flow (FBF), and vascular resistance (FVR) were made before and during two minutes of grip at 75% of maximum voluntary contraction with a hand held dynamometer (Model EM-50 Psytech, Denmark).
The lower body negative pressure (LBNP) test was then used to test parasympathetic afferent function. At low levels of LBNP there is no change in arterial pressure or heart rate, so the activity of the cardiopulmonary afferents can be determined without involvement of other baroreceptors.14 A sympathetic efferent a mediated vasoconstrictor response is measured, '5 16 but provided the efferent limb of the pathway can be shown to be intect, it can be used to determine parasympathetic afferent function. The subject was placed in a chamber sealed below the ribs and -10 mm Hg suction applied for one minute. Heart rate, mean arterial pressure, FBF, and FVR were recorded before and after one minute of suction.
The cold pressor test was t-hen used as a test of sympathetic efferent function: 17 18 cardiac ,8l adrenoreceptor function was assessed by changes in heart rate, and peripheral a adrenoreceptor function was assessed by changes in FBF and FVR. Measurements of FBF, FVR, mean arterial pressure, and heart rate were made before and after one minute of immersion of the forearm in ice. PLETHYSMOGRAPHIC 
MEASUREMENTS
We used a calibrated mercury in rubber strain gauge plethysmograph (Medimatic SP 2, Denmark). A venous cuff was placed above the right elbow and the strain gauge around the widest part of the right forearm. A hand cuff was not used as hand circulation was previously shown not to affect measurements of flow, and caused discomfort when at more than systolic pressure. 
Results
PATIENT CHARACTERISTICS
Fifty patients were studied who had significant angiographic disease and evidence of ambulatory ischaemia. Twenty five were allocated to group 1 (with silent ischaemia), 25 to group 2 (with symptomatic ischaemia), and there were 21 controls. Table 1 summarises the patient characteristics. There were no hypertensive controls, and the number of hypertensive patients in both ischaemic groups was similar. The mean arterial pressure of the 17 hypertensive patients was higher than that of the remaining 33 ischaemic patients of both groups (116-3 (2-4)mmHg v 100'6 (1P4)mmHg, p < 0.0001). There were more patients taking fi Blockers* (n(%))
9 (25) 16 (64) *p < 0 05 between groups 1 and 2.
A, angina; PIA, postinfarction angina; PIS, postinfarction exercise silent ischaemia; S, pure silent ischaemia. (72) with symptoms (n (%)) Positive tests* 17 (68) 1 (4) without symptoms (n (%)) Mean (SEM) exercise 7 9 (0 5) fl-blockers before the study in group 2 than group 1 (p < 0 05). One patient in group 1 had diabetes mellitus.
ISCHAEMIC CHARACTERISTICS
There was no evidence of mitral regurgitation. The distribution and number of diseased vessels was not significantly different in groups 1 and 2 (table 2) . Table 2 shows the characteristics of the exercise tests. Three patients in group 2 and one in group 1 had negative exercise tests. More patients had a symptomatic positive exercise test in group 2 than in group 1 (p < 0-001). In the patients with positive tests, the ischaemic threshold (time to 1 mm ST depression), heart rate at the ischaemic threshold, and mean maximum ST depression were similar in both groups. The number of fixed and reversible thallium defects in both ischaemic groups was similar. In group 1, we found eight fixed defects in seven patients: one anterior, one inferior, one inferolateral, one septal, and three posterolateral; and 33 reversible defects in 22 patients: six anterior, three anterolateral, 16 inferior, two septal, three posterolateral, and three apical. In group 2 we found 10 fixed defects in seven patients: three anterior, three inferior, three posterolateral, and one apical; and 31 reversible defects in 22 patients: five anterior, 12 inferior, eight septal, and six posterolateral. The reversible defects were silent in 16 patients of group 1 and only one patient of group 2 (p < 0-001).
In group 1, the duration of ambulatory silent ischaemia was 21-0 (4-5) minutes occurring for a mean of 2-5 (0-4) episodes. In group 2, the duration of ambulatory symptomatic ischaemia was 25-2 (5-5) minutes occurring for 2-5 (0-4) episodes. In group 2, 17 patients had 25-3 (5-5) minutes of ambulatory silent ischaemia occurring for a mean of 3-4 (0-4) episodes, which was not significantly different from group 1.
PARASYMPATHETIC EFFERENT TESTS
The Valsalva ratio in both ischaemic groups was lower than that of the controls but the difference was not significant (table 3) .
Heart rate variation in response to deep breathing and after standing up was performed in 17 patients from group 1, 10 patients from group 2, and 18 controls. Heart rate variation during deep breathing was similar in all groups. Heart rate variation on standing was significantly greater in the controls than both groups 1 and 2 (p < 0 005 and p < 0.01).
LOWER BODY NEGATIVE PRESSURE TEST
In all three groups, mean arterial pressure did not change significantly during suction (table 4). The FBF decreased and FVR increased significantly during suction in each group, but the change in these variables did not differ significantly between the groups.
COLD PRESSOR TEST
In all groups, heart rate, mean arterial pressure, and FVR increased and FBF decreased tP < 0 02 between group 1 and 2, and p < 0 04 between group 2 and controls. 4:p < 0-02 between group I and 2, and p < 0 03 between group 2 and controls. §p < 0 01 between group 1 and 2. 1P < 0 01 between group 1 and 2 and p < 0 01 between group 2 and controls.
Abbreviations as for tables 4 and 5. significantly in the first minute of cold immersion ( In the first minute of isometric handgrip, FBF, mean arterial pressure, and heart rate increased and FVR decreased significantly in the three groups (table 6 and figure) . In group 1, the increase in FBF was significantly greater than in group 2 (p < 0.02) and in the controls (p < 0-04). The decrease in FVR in the first minute was significantly greater in group 1 than group 2 (p < 0-001). The mean arterial pressure and heart rate changes in the first minute were similar in the three groups.
Between the first and second minute, FBF and FVR remained unchanged in group 1 and the controls, but in group 2, FBF increased further (p < 0 02) and FVR decreased further (p < 0 03). In the three groups, heart rate remained unchanged and mean arterial pressure increased only in the controls (p < 0-0001) between the first and second minute.
Overall up to two minutes, the changes in FBF, FVR, mean arterial pressure, and heart rate did not differ significantly between the groups.
DIFFERENCES IN AUTONOMIC FUNCTION IN PURE SILENT ISCHAEMIA
Four patients from group 1 had pure silent ischaemia, and the remaining 21 either had a history of angina, or a painful myocardial infarction and a subsequent silent or symptomatic positive exercise test. The autonomic responses to the Valsalva, LBNP, cold pressor, and isometric handgrip tests were compared between these two subgroups of group 1. The Valsalva ratios were not significantly different between the two subgroups. The decrease in FVR during LBNP was significant (table 7) in the group with pure silent ischaemia but the magnitude of change was not significantly different from the remaining patients with silent ischaemia or the controls. The changes in FBF and FVR during one minute of hand grip and the cold pressor test were not significant in the subgroup with pure silent ischaemia. After one minute of the cold pressor test FBF fell non-significantly (p < 0-0001). In the group with pure silent ischaemia, but in the remaining patients it decreased significantly (p < 0-0001). In the group with pure silent ischaemia, FVR increased non-significantly (by 100-9% (88 0%)). In the remaining patients in group 1 the increase of 143-0% (32 5%) was significant (p < 0-005).
After one minute of isometric handgrip in the patients with pure silent ischaemia, FBF increased by 36-9% (12-6%, NS). In the remaining patients, FBF increased by 87-4% (10-8%, p < 0-0001). The FVR decreased non-significantly in the group with pure silent ischaemia (by 19-2% (9 0%)), and significantly in the remaining patients in group 1 (by 36 Baseline '9 In our study only mildly hypertensive patients were included, with similar numbers in both ischaemic groups. The similarity of cold pressor and LBNP responses between the groups suggests that the hypertensive component of both ischaemic groups was unlikely to have affected the results.
Although chronic with fl, blockers treatment is thought to result in up regulation of fi receptors,2' recent evidence from Hall et al suggests that treatment of human atrial myocardium with the fil blocker atenolol resulted in increased cardiac /2 activity.22 This would result in an enhanced ability to vasodilate in the symptomatic group who had been on /3 blockers (nearly all took atenolol). Indeed, this was not the case, as the patients with silent ischaemia had a significantly greater propensity to vasodilate during isometric handgrip than the symptomatic patients. More There was a trend towards a greater duration of exercise tests, as expected in the silent ischaemic group. The severity of ischaemic heart disease in groups 1 and 2 was, however, similar based on exercise, thallium scintigraphic, and angiographic criteria, and was thought to represent moderately severe disease.23 This is expected as it is claimed that ambulatory ischaemia is only likely to be detected in at least moderately severe disease. 24 that patients with silent ischaemia are no less at risk of these sequelae than symptomatic patients.
In animals, others have previously shown that myocardial ischaemia can stimulate both sympathetic30-32 and parasympathetic cardiac afferents.3 Ischaemic stimulation of sympathetic afferents has been shown to reduce the threshold of ventricular fibrillation, providing a possible mechanism for arrhythmogenesis.34 Furthermore, Schwartz et al showed that cardiac parasympathetic afferent stimulation reduces sympathetic efferent activity, which theoretically could reduce the risk of arrhythmogenesis. The fact that there was no difference in cardiac parasympathetic afferent function between the silent and symptomatic ischaemic groups and controls suggests that they are unlikely to be involved in the prevention of ventricular arrhythmia (by modulating sympathetic efferent activity) in patients with ischaemic heart disease. To examine this further, however, cardiac parasympathetic afferent function should be studied in patients with and without ventricular arrhythmia after myocardial infarction.
CARDIAC SYMPATHETIC FUNCTION
Previous studies have shown a higher incidence of silent ischaemia in patients with diabetes mellitus and autonomic neuropathy9 '0 but failed to identify the type of neuropathy. Our findings suggest that rather than reduced autonomic responses, patients with silent ischaemia had an enhanced autonomic response because of increased forearm vasodilation. This is likely to reflect the composition of the silent ischaemic group. In patients with pure silent ischaemia generalised sympathetic dysfunction was shown with non-significant responses to handgrip and cold immersion compared with controls and the remaining patients in group 1. In these patients with pure silent ischaemia, a neuropathy would be anticipated as they had never experienced chest pain. In the remaining patients (most of group 1) a neuropathy would perhaps not be anticipated as the patients had experienced angina previously. Some patients with silent ischaemia had a previous myocardial infarction. Such patients may have had intact pain pathways that were disrupted by the infarction process.
There is some controversy over the mechanism of vasodilation during isometric handgrip. Eklund A 24-year-old man was admitted with a 5-day history of giddiness, a cough with whitish expectoration, breathlessness, and orthopnoea. The patient showed no marfanoid features. He was afebrile but dyspnoeic. His pulse (40 beats/min) was regular and he showed raised jugular venous pulsation with visible cannon waves. Blood pressure was 130/60 mm Hg. At auscultation an early diastolic murmur (grade 2/6) was heard at the lower sternal edge. An electrocardiogram showed complete heart block, and a chest x ray taken with portable equipment showed cardiomegaly and frank pulmonary oedema. All haematological and biochemical variables were normal. Three blood cultures were negative. Cross sectional echocardiography confirmed the diagnosis of a dilated, unruptured aneurysm of the right coronary sinus dissecting into the interventricular septum and producing a cystic mass ( fig A) . Cardiac catheterisation confirmed the presence of an unruptured aneurysm of the right sinus of Valsalva dissecting into the upper part of the interventricular septum with grade 2/6 aortic regurgitation. There was no gradient across the outflow tract. The results of selective coronary angiography were normal.
The patient was treated for heart failure with intravenous frusemide and supplementary potassium and a transvenous temporary pacing wire was inserted. He underwent cardiopulmonary surgery. The ostium of the aneurysm was closed with Dacron patch and a permanent pacemaker was implanted. Postoperatively cross sectional echocardiography showed signs of mild aortic regurgitation. The cystic cavity in the septum had been completely obliterated (fig B) .
Unruptured aneurysm of sinus of Valsalva is a rare anomaly that commonly affects the right coronary sinus.' The aneurysm may present clinically as aortic regurgitation2 or as a mediastinal mass,3 cerebrovascular accident,4 or complete heart block.5 Some patients have presented with dyspnoea on exertion (NYHA functional class II). 6 Our patient was orthopnoeic (NYHA functional class IV) with clinical and radiological features of frank pulmonary oedema. His condition improved considerably after successful surgical repair.
